Atogepant

Atogepant
Generic Name/API:Atogepant
Packaging:1 Bottle of 30 tablets
Storage:Store at 20°C and 25°C
Dosage:For dosage information, please check the General Information section.
Strength:Tablets: 10 mg, 30 mg, and 60 mg.
Indication:Qulipta is an oral, once‑daily tablet in the class of CGRP receptor antagonists ("gepants") used for the prevention of migraines in adults

QULIPTA / AQUIPTA (Atogepant) is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of episodic migraine in adults

Strength: 

Tablets: 10 mg, 30 mg, and 60 mg.

Dosage:  

The recommended dosage is 10 mg, 30 mg, or 60 mg taken orally once daily with or without food.

Dosage Modifications for Drug Interactions and for Specific Populations 

  • Strong CYP3A4 Inhibitors – 10 mg OD
  • Strong and Moderate CYP3A4 Inducers – 30 mg or 60 mg  OD
  • OATP Inhibitors- )  – 10 mg or 30 mg Renal Impairment OD
  • Severe Renal Impairment and End-Stage Renal Disease (CLcr <30 mL/min) (8.6)  – 10 mg OD

Side effects of Atogepant:

  • Constipation
  • Nausea
  • Fatigue
  • Sleepiness (drowsiness)
  • Decreased appetite

Most are mild and go away over time. If side effects persist, consult your doctor.

Storage : 

  • 20°C and 25°C
  • Pregnancy and Breastfeeding: There isn’t enough data to definitively assess the risks of AQUIPTA during pregnancy. If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your doctor. They will help you weigh the options.
  • Severe Kidney or Liver Impairment: Dosing adjustments may be necessary for individuals with moderate kidney impairment, and AQUIPTA is generally not recommended for those with severe kidney impairment or end-stage renal disease. Similarly, it’s not recommended for people with severe liver impairment. Your doctor will assess your kidney and liver function before prescribing and adjust as needed.
  • Elderly Patients: While generally safe, older adults may be more susceptible to certain side effects. Your doctor will consider your overall health when prescribing.

Process to Import Medicine

FAQ

Atogepant blocks the calcitonin gene-related peptide (CGRP) receptor, which plays a key role in triggering migraines. By blocking CGRP activity, it helps reduce migraine frequency and severity.

Take one 10 mg tablet once daily, with or without food, at the same time each day. Follow your doctor’s instructions precisely.

Avoid Atogepant if you:

  • Are allergic to it or any of its ingredients
  • Have severe liver disease
  • Are on strong CYP3A4 inhibitors/inducers (check with your doctor)
  • Are pregnant or breastfeeding (unless cleared by a doctor)

  • Constipation
  • Nausea
  • Fatigue
  • Sleepiness (drowsiness)
  • Decreased appetite

Most are mild and go away over time. If side effects persist, consult your doctor.

Yes, but only under medical supervision. You may still use acute migraine treatments (like triptans or NSAIDs) if needed. Always inform your doctor of all medications you take.

No. Atogepant is not addictive or habit-forming.

Some people see a reduction in migraine days within 1–2 weeks, but full benefits are usually seen by 12 weeks. Continue use as prescribed.

The cost of qulipta / aquipta (atogepant) tablets in India varies as it must be imported. Supplier availability, import duties, and currency fluctuations can affect the final price. For the latest cost details, contact 24/7QualityMeds at +91 9967979080.

To buy qulipta / aquipta (atogepant) tablets in India at a genuine price, contact 24/7QualityMeds. We assist with prescription verification, import process, sourcing from reliable suppliers, and safe delivery.

While selecting a supplier, we essentially ensure that the supplier holds a valid Good Distribution Practice (GDP) certificate and possesses a valid operating license. These credentials confirm that the suppliers adherence to International standards for the proper distribution of medicinal product

Related products